Portugal

Rovi explores sale of drug manufacturing unit to third parties

Spanish pharmaceutical company Rovi announced on Thursday that it has leased asset control and money advisory firm Lazard to explore the sale of its third-party production business that it uses to make COVID vaccines. Madrid-based Rovi said it is evaluating potential strategic opportunities to maximize the price. and has taken the decision to rent Lazard, although no express resolution has been taken and the investigation is still ongoing.

Rovi explores sale of drug manufacturing unit to third parties Read More »